abrdn Life Sciences Investors (NYSE:HQL – Get Free Report) declared a quarterly dividend on Thursday, November 9th, NASDAQ reports. Investors of record on Wednesday, November 22nd will be paid a dividend of 0.30 per share on Wednesday, January 10th. This represents a $1.20 annualized dividend and a yield of 9.95%. The ex-dividend date of this dividend is Tuesday, November 21st.
abrdn Life Sciences Investors has decreased its dividend by an average of 1.0% per year over the last three years.
abrdn Life Sciences Investors Stock Up 1.3 %
HQL stock opened at $12.06 on Friday. abrdn Life Sciences Investors has a 12 month low of $11.34 and a 12 month high of $15.25. The firm’s fifty day simple moving average is $12.23 and its 200-day simple moving average is $13.05.
Insider Activity at abrdn Life Sciences Investors
Institutional Investors Weigh In On abrdn Life Sciences Investors
Several hedge funds have recently modified their holdings of the company. Money Concepts Capital Corp acquired a new position in abrdn Life Sciences Investors in the 4th quarter worth about $160,000. B. Riley Wealth Advisors Inc. acquired a new position in shares of abrdn Life Sciences Investors during the 4th quarter worth approximately $167,000. Cambridge Investment Research Advisors Inc. purchased a new position in shares of abrdn Life Sciences Investors during the 1st quarter valued at approximately $168,000. IHT Wealth Management LLC purchased a new position in shares of abrdn Life Sciences Investors during the 1st quarter valued at approximately $170,000. Finally, Eudaimonia Partners LLC acquired a new stake in abrdn Life Sciences Investors in the 1st quarter valued at $199,000. 19.70% of the stock is owned by hedge funds and other institutional investors.
abrdn Life Sciences Investors Company Profile
Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries.
- Five stocks we like better than abrdn Life Sciences Investors
- Why is the Ex-Dividend Date Significant to Investors?
- S&P 500’s Whirlwind: Big gains, warning whispers & tactical moves
- How to Invest in Music Stocks
- MarketBeat Week in Review – 11/13 – 11/17
- What Are Dividend Champions? How to Invest in the Champions
- 3 large caps with red hot RSIs with upside
Receive News & Ratings for abrdn Life Sciences Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for abrdn Life Sciences Investors and related companies with MarketBeat.com's FREE daily email newsletter.